TrialAnnals of oncology : official journal of the European Society for Medical Oncology2016

Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence.

E A Mittendorf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.